These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38522265)

  • 1. Host determinants and responses underlying SARS-CoV-2 liver tropism.
    Heinen N; Klöhn M; Westhoven S; Brown RJ; Pfaender S
    Curr Opin Microbiol; 2024 Jun; 79():102455. PubMed ID: 38522265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging SARS-CoV-2 variants can potentially break set epidemiological barriers in COVID-19.
    Kumar A; Parashar R; Kumar S; Faiq MA; Kumari C; Kulandhasamy M; Narayan RK; Jha RK; Singh HN; Prasoon P; Pandey SN; Kant K
    J Med Virol; 2022 Apr; 94(4):1300-1314. PubMed ID: 34811761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry.
    Wei C; Wan L; Yan Q; Wang X; Zhang J; Yang X; Zhang Y; Fan C; Li D; Deng Y; Sun J; Gong J; Yang X; Wang Y; Wang X; Li J; Yang H; Li H; Zhang Z; Wang R; Du P; Zong Y; Yin F; Zhang W; Wang N; Peng Y; Lin H; Feng J; Qin C; Chen W; Gao Q; Zhang R; Cao Y; Zhong H
    Nat Metab; 2020 Dec; 2(12):1391-1400. PubMed ID: 33244168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host proviral and antiviral factors for SARS-CoV-2.
    Lv L; Zhang L
    Virus Genes; 2021 Dec; 57(6):475-488. PubMed ID: 34510331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2.
    Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
    Cells; 2021 Jun; 10(6):. PubMed ID: 34201214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How SARS-CoV-2 (COVID-19) spreads within infected hosts - what we know so far.
    Sanyal S
    Emerg Top Life Sci; 2020 Dec; 4(4):371-378. PubMed ID: 33269805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of common medications on the expression of SARS-CoV-2 entry receptors in liver tissue.
    Saheb Sharif-Askari N; Saheb Sharif-Askari F; Mdkhana B; Al Heialy S; Ratemi E; Alghamdi M; Abusnana S; Kashour T; Hamid Q; Halwani R
    Arch Toxicol; 2020 Dec; 94(12):4037-4041. PubMed ID: 32808185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variants in ACE2; potential influences on virus infection and COVID-19 severity.
    Bakhshandeh B; Sorboni SG; Javanmard AR; Mottaghi SS; Mehrabi MR; Sorouri F; Abbasi A; Jahanafrooz Z
    Infect Genet Evol; 2021 Jun; 90():104773. PubMed ID: 33607284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a special cell type as a determinant of the kidney tropism of SARS-CoV-2.
    Lin H; Ma X; Xiao F; Su H; Shi Y; Liu Y; Song L; Zhang Z; Zhang C; Peng H
    FEBS J; 2021 Sep; 288(17):5163-5178. PubMed ID: 34228902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular diversity of coronavirus host cell entry receptors.
    Millet JK; Jaimes JA; Whittaker GR
    FEMS Microbiol Rev; 2021 May; 45(3):. PubMed ID: 33118022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids.
    Yang L; Han Y; Nilsson-Payant BE; Gupta V; Wang P; Duan X; Tang X; Zhu J; Zhao Z; Jaffré F; Zhang T; Kim TW; Harschnitz O; Redmond D; Houghton S; Liu C; Naji A; Ciceri G; Guttikonda S; Bram Y; Nguyen DT; Cioffi M; Chandar V; Hoagland DA; Huang Y; Xiang J; Wang H; Lyden D; Borczuk A; Chen HJ; Studer L; Pan FC; Ho DD; tenOever BR; Evans T; Schwartz RE; Chen S
    Cell Stem Cell; 2020 Jul; 27(1):125-136.e7. PubMed ID: 32579880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2.
    Zhao X; Zheng S; Chen D; Zheng M; Li X; Li G; Lin H; Chang J; Zeng H; Guo JT
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiological mechanisms of liver injury in COVID-19.
    Nardo AD; Schneeweiss-Gleixner M; Bakail M; Dixon ED; Lax SF; Trauner M
    Liver Int; 2021 Jan; 41(1):20-32. PubMed ID: 33190346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of hepatitis C virus entry on viral tropism.
    Ding Q; von Schaewen M; Ploss A
    Cell Host Microbe; 2014 Nov; 16(5):562-8. PubMed ID: 25525789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19.
    Senapati S; Banerjee P; Bhagavatula S; Kushwaha PP; Kumar S
    J Genet; 2021; 100(1):. PubMed ID: 33707363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroinvasion and neurotropism of severe acute respiratory syndrome coronavirus 2 infection.
    Jagst M; Pottkämper L; Gömer A; Pitarokoili K; Steinmann E
    Curr Opin Microbiol; 2024 Jun; 79():102474. PubMed ID: 38615394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?
    Elrashdy F; Redwan EM; Uversky VN
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32933047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19-from mucosal immunology to IBD patients.
    Weidinger C; Hegazy AN; Glauben R; Siegmund B
    Mucosal Immunol; 2021 May; 14(3):566-573. PubMed ID: 33608656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.
    Wang Y; Liu S; Liu H; Li W; Lin F; Jiang L; Li X; Xu P; Zhang L; Zhao L; Cao Y; Kang J; Yang J; Li L; Liu X; Li Y; Nie R; Mu J; Lu F; Zhao S; Lu J; Zhao J
    J Hepatol; 2020 Oct; 73(4):807-816. PubMed ID: 32437830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The viral protein fragment theory of COVID-19 pathogenesis.
    Suzuki YJ
    Med Hypotheses; 2020 Nov; 144():110267. PubMed ID: 33254571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.